A First-of-Its-Kind Library of Potential Coronavirus Drugs, Built at Columbia University, Funded by China ’s Richest Person
If our experience with coronaviruses in the past few decades has taught us anything, it’s that outbreaks are inevitable, no matter what we do. You don’t have to look further than the fact that COVID-19 is the third coronavirus epidemic to affect human populations in 20 years, after severe acute respiratory syndromes (SARS) in 2003 and Middle East respiratory syndrome (MERS) in 2012. Coronaviruses make their homes in a variety of animal hosts, from bats to cats, dogs to camels, and it’s just a matter of time before another one makes the jump into people. Another thing we know for sure is that we can’t rely on patchwork responses each time an outbreak occurs. Every time a new coronavirus emerges, researchers focus their attention on learning everything they can about the culprit, and biotech companies dip a careful toe into the investigational waters of developing a new treatment, but ultimately, when the cases subside, so does the interest and so does the research. Dr. David Ho, director of the Aaron Diamond AIDS Research Center and professor of medicine at Columbia University, wants to put an end to that trend. Ho is a leader in the HIV field, having done groundbreaking research on how the virus works in the body, and pioneering the idea of combating infection early and with the strongest possible arsenal of combined anti-virals. Now, he’s turning to coronaviruses, hoping his HIV expertise will help him figure out how best to treat and contain n...
Publication date: Available online 2 April 2020Source: Journal of Clinical Orthopaedics and TraumaAuthor(s): Robert U. Ashford, Jennifer S. Nichols, Jitendra Mangwani
Conclusion: Abstinence from alcohol following AC/AH diagnosis was achieved in 39% of patients. Abstinence was not related to increased survival for alcoholic liver disease patients at one-year, which might partly indicate that this might be a marker that some patients were 'too sick to drink'. AC and AH patients who survived one year and remained abstinent had a favorable long-term prognosis. PMID: 32233877 [PubMed - as supplied by publisher]
The eye-catching spikes sticking out from the surface of SARS-CoV-2 may inspire new ways to prevent or treat Covid-19 infections.Knowable Magazine
Publication date: Available online 3 April 2020Source: Journal of Minimally Invasive GynecologyAuthor(s): Stephanie N Morris, Amanda Nickles Fader, Magdy P Milad, Humberto J Dionisi
Publication date: Available online 3 April 2020Source: Journal of Minimally Invasive GynecologyAuthor(s): Jubilee Brown
Publication date: Available online 3 April 2020Source: Journal of Minimally Invasive GynecologyAuthor(s): Sarah L. Cohen, Grace Liu, Mauricio Abrao, Neil Smart, Todd Heniford
Publication date: Available online 2 April 2020Source: European Journal of Obstetrics &Gynecology and Reproductive BiologyAuthor(s): Gabriele Saccone, Floriana Carbone, Fulvio Zullo
Publication date: 12 April 2020Source: Nutrition, Metabolism and Cardiovascular Diseases, Volume 30, Issue 4Author(s): Huanhuan Wang, Ying Song, Xiaofang Tang, Jingjing Xu, Ping Jiang, Lin Jiang, Zhan Gao, Jue Chen, Lei Song, Yin Zhang, Xueyan Zhao, Shubin Qiao, Yuejin Yang, Runlin Gao, Bo Xu, Jinqing Yuan, Lijian Gao
CORONAVIRUS symptoms seem to be bringing new developments daily causing many to panic. The best determination of true symptoms is other people's accounts. Linda Lusardi describes her very unusual symptoms warning others.
Perhaps half the world's population is under some form of lockdown to help curb the spread of coronavirus. Many are starting to wonder when and how these tough restrictions on everyday life will end. Could a so-called immunity passport be the answer?
More News: Biotechnology | China Health | Coronavirus | COVID-19 | Databases & Libraries | Epidemics | Epidemiology | Funding | Genetics | Grants | Health | Hepatitis | HIV AIDS | Infectious Diseases | Learning | MERS | Middle East Health | Outbreaks | Politics | Respiratory Medicine | SARS | Universities & Medical Training | Wuhan Coronavirus